☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Pharming
Insights+: The US FDA New Drug Approvals in March 2023
April 19, 2023
Pharming’s Joenja (leniolisib) Receives the US FDA’s Approval as First Treatment for Activated Phosphoinositide 3-Kinase Delta Syn...
March 27, 2023
Pharming’s MAA Application for Leniolisib Receives Approval by the EMA to Treat Activated Phosphoinositide 3-Kinase Delta Syndrome
October 28, 2022
PharmaShots Weekly Snapshot (January 20-24, 2020)
January 27, 2020
PharmaShots Weekly Snapshot (Dec 30, 2019-Jan 03, 2020)
January 6, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.